Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Jul, 7 2025
Apr, 4 2026
Nov, 16 2025
Dec, 20 2025
Oct, 22 2025